首页> 外文期刊>BMC Veterinary Research >The development of an indirect ELISA for the detection of goose parvovirus antibodies using specific VP3 subunits as the coating antigen
【24h】

The development of an indirect ELISA for the detection of goose parvovirus antibodies using specific VP3 subunits as the coating antigen

机译:使用特异性VP3亚基作为包被抗原的间接检测鹅细小病毒抗体的ELISA方法的开发

获取原文
           

摘要

In Poland, the leader in goose production in Europe, goose parovirus infection, or Derzsy’s disease (DD), must be reported to the veterinary administration due to the serious economic and epizootic threat to waterfowl production. Prophylactic treatment for DD includes attenuated live or inactivated vaccines. Moreover, the control of DD includes the monitoring of maternal derived antibody (MDA) levels in the offspring and antibody titers in the parent flock after vaccination. The aim of this study was to develop an ELISA for the detection of goose parvovirus (GPV) antibodies. Two recombinant protein fragments derived from VP3 (viral protein 3) GPV, namely VP3ep6 and VP3ep4–6 with a mass of 20.9 and 32.3?kDa, respectively, were produced using an Escherichia coli expression system. These proteins were purified by one-step nickel-affinity chromatography, which yielded protein preparations with a purity above 95%. These recombinant proteins were useful in the detection of serum anti-GPV antibodies, and this was confirmed by Western blotting. However, recombinant VP3ep4–6 protein showed a greater ability to correctly identify sera from infected geese. In the next stage of the project, a pool of 166 goose sera samples, previously examined by a virus neutralization test (VN), was tested. For further studies, one recombinant protein (VP3ep4–6) was selected for optimization of the test conditions. After optimization, the newly developed ELISA was compared to other serological tests, and demonstrated high sensitivity and specificity. In conclusion, the VP3ep4–6 ELISA method described here can be used for the detection of antibodies to GPV in serum.
机译:在波兰,由于对水禽生产造成严重的经济和动物流行威胁,因此必须向兽医部门报告欧洲鹅生产的领导者,鹅腮病毒感染或Derzsy病(DD)。 DD的预防性治疗包括减毒活疫苗或灭活疫苗。此外,DD的控制包括监测接种疫苗后代的母源抗体(MDA)水平和亲代鸡群的抗体滴度。这项研究的目的是开发一种用于检测鹅细小病毒(GPV)抗体的ELISA。使用大肠杆菌表达系统生产了两个分别来自VP3(病毒蛋白3)GPV的重组蛋白片段,即VP3ep6和VP3ep4-6,其质量分别为20.9和32.3?kDa。这些蛋白质通过一步镍亲和层析纯化,得到纯度高于95%的蛋白质制品。这些重组蛋白可用于检测血清抗GPV抗体,这已通过蛋白质印迹法得到证实。但是,重组VP3ep4-6蛋白显示出从被感染的鹅中正确鉴定血清的更大能力。在该项目的下一阶段,测试了166个鹅血清样品池,这些样品先前已通过病毒中和测试(VN)进行了检查。为了进一步研究,选择了一种重组蛋白(VP3ep4-6)来优化测试条件。优化后,将新开发的ELISA与其他血清学测试进行比较,并显示出高灵敏度和特异性。总之,此处描述的VP3ep4-6 ELISA方法可用于检测血清中抗GPV的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号